Cargando…

The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure

BACKGROUND: Lung immaturity due to preterm birth is a significant complication affecting neonatal health. Despite the detrimental effects of supplemental oxygen on alveolar formation, it remains an important treatment for infants with respiratory distress. Macrophages are traditionally associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Christina V, Alikhan, Maliha A, O’Reilly, Megan, Sozo, Foula, Williams, Timothy M, Harding, Richard, Jenkin, Graham, Ricardo, Sharon D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172892/
https://www.ncbi.nlm.nih.gov/pubmed/25192716
http://dx.doi.org/10.1186/s12931-014-0110-5
_version_ 1782336094460706816
author Jones, Christina V
Alikhan, Maliha A
O’Reilly, Megan
Sozo, Foula
Williams, Timothy M
Harding, Richard
Jenkin, Graham
Ricardo, Sharon D
author_facet Jones, Christina V
Alikhan, Maliha A
O’Reilly, Megan
Sozo, Foula
Williams, Timothy M
Harding, Richard
Jenkin, Graham
Ricardo, Sharon D
author_sort Jones, Christina V
collection PubMed
description BACKGROUND: Lung immaturity due to preterm birth is a significant complication affecting neonatal health. Despite the detrimental effects of supplemental oxygen on alveolar formation, it remains an important treatment for infants with respiratory distress. Macrophages are traditionally associated with the propagation of inflammatory insults, however increased appreciation of their diversity has revealed essential functions in development and regeneration. METHODS: Macrophage regulatory cytokine Colony-Stimulating Factor-1 (CSF-1) was investigated in a model of neonatal hyperoxia exposure, with the aim of promoting macrophages associated with alveologenesis to protect/rescue lung development and function. Neonatal mice were exposed to normoxia (21% oxygen) or hyperoxia (Hyp; 65% oxygen); and administered CSF-1 (0.5 μg/g, daily × 5) or vehicle (PBS) in two treatment regimes; 1) after hyperoxia from postnatal day (P)7-11, or 2) concurrently with five days of hyperoxia from P1-5. Lung structure, function and macrophages were assessed using alveolar morphometry, barometric whole-body plethysmography and flow cytometry. RESULTS AND DISCUSSION: Seven days of hyperoxia resulted in an 18% decrease in body weight and perturbation of lung structure and function. In regime 1, growth restriction persisted in the Hyp + PBS and Hyp + CSF-1 groups, although perturbations in respiratory function were resolved by P35. CSF-1 increased CSF-1R+/F4/80+ macrophage number by 34% at P11 compared to Hyp + PBS, but was not associated with growth or lung structural rescue. In regime 2, five days of hyperoxia did not cause initial growth restriction in the Hyp + PBS and Hyp + CSF-1 groups, although body weight was decreased at P35 with CSF-1. CSF-1 was not associated with increased macrophages, or with functional perturbation in the adult. Overall, CSF-1 did not rescue the growth and lung defects associated with hyperoxia in this model; however, an increase in CSF-1R+ macrophages was not associated with an exacerbation of lung injury. The trophic functions of macrophages in lung development requires further elucidation in order to explore macrophage modulation as a strategy for promoting lung maturation.
format Online
Article
Text
id pubmed-4172892
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41728922014-09-25 The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure Jones, Christina V Alikhan, Maliha A O’Reilly, Megan Sozo, Foula Williams, Timothy M Harding, Richard Jenkin, Graham Ricardo, Sharon D Respir Res Research BACKGROUND: Lung immaturity due to preterm birth is a significant complication affecting neonatal health. Despite the detrimental effects of supplemental oxygen on alveolar formation, it remains an important treatment for infants with respiratory distress. Macrophages are traditionally associated with the propagation of inflammatory insults, however increased appreciation of their diversity has revealed essential functions in development and regeneration. METHODS: Macrophage regulatory cytokine Colony-Stimulating Factor-1 (CSF-1) was investigated in a model of neonatal hyperoxia exposure, with the aim of promoting macrophages associated with alveologenesis to protect/rescue lung development and function. Neonatal mice were exposed to normoxia (21% oxygen) or hyperoxia (Hyp; 65% oxygen); and administered CSF-1 (0.5 μg/g, daily × 5) or vehicle (PBS) in two treatment regimes; 1) after hyperoxia from postnatal day (P)7-11, or 2) concurrently with five days of hyperoxia from P1-5. Lung structure, function and macrophages were assessed using alveolar morphometry, barometric whole-body plethysmography and flow cytometry. RESULTS AND DISCUSSION: Seven days of hyperoxia resulted in an 18% decrease in body weight and perturbation of lung structure and function. In regime 1, growth restriction persisted in the Hyp + PBS and Hyp + CSF-1 groups, although perturbations in respiratory function were resolved by P35. CSF-1 increased CSF-1R+/F4/80+ macrophage number by 34% at P11 compared to Hyp + PBS, but was not associated with growth or lung structural rescue. In regime 2, five days of hyperoxia did not cause initial growth restriction in the Hyp + PBS and Hyp + CSF-1 groups, although body weight was decreased at P35 with CSF-1. CSF-1 was not associated with increased macrophages, or with functional perturbation in the adult. Overall, CSF-1 did not rescue the growth and lung defects associated with hyperoxia in this model; however, an increase in CSF-1R+ macrophages was not associated with an exacerbation of lung injury. The trophic functions of macrophages in lung development requires further elucidation in order to explore macrophage modulation as a strategy for promoting lung maturation. BioMed Central 2014-09-06 2014 /pmc/articles/PMC4172892/ /pubmed/25192716 http://dx.doi.org/10.1186/s12931-014-0110-5 Text en © Jones et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jones, Christina V
Alikhan, Maliha A
O’Reilly, Megan
Sozo, Foula
Williams, Timothy M
Harding, Richard
Jenkin, Graham
Ricardo, Sharon D
The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure
title The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure
title_full The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure
title_fullStr The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure
title_full_unstemmed The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure
title_short The effect of CSF-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure
title_sort effect of csf-1 administration on lung maturation in a mouse model of neonatal hyperoxia exposure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172892/
https://www.ncbi.nlm.nih.gov/pubmed/25192716
http://dx.doi.org/10.1186/s12931-014-0110-5
work_keys_str_mv AT joneschristinav theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT alikhanmalihaa theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT oreillymegan theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT sozofoula theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT williamstimothym theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT hardingrichard theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT jenkingraham theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT ricardosharond theeffectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT joneschristinav effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT alikhanmalihaa effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT oreillymegan effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT sozofoula effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT williamstimothym effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT hardingrichard effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT jenkingraham effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure
AT ricardosharond effectofcsf1administrationonlungmaturationinamousemodelofneonatalhyperoxiaexposure